\
&
Contact us
Starts in 2 days from now
Locationonline
ProgrammesFrom April 20-22 2026, EIC-funded companies can participate in training sessions designed to develop the knowledge and practical skills needed to engage in public and private procurement opportunities in Europe and beyond, wit the objective of helping them scale up their business.
Yearly over 250 000 EU public authorities spend around 14% of GDP (around €2 trillion ) procuring services, works and supplies. An increasing share of this is dedicated to procuring innovation. Innovation Procurement allows suppliers of innovative solution to engage in early discussions with potential buyers, helping new and disruptive innovations find their way into tenders.
Are you interested in learning how to leverage public and private innovation procurement to scale your business?
Within the context of the EIC Innovation Procurement Programme powered by SPIN4EIC, EIC Awardees are invited to take part in the next , fully online, edition of the EIC Innovation Procurement Academy, taking place from 20 to 22 April 2026.
Find out more on the event & apply by 27 March 2026!
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
The Horizon2020 project BEAT-AF brings together 9 European renowned clinical centres in France, Belgium, Czechia, Germany and Austria. Together, the consortium strives to revolutionize Atrial Fibrillation (AF) treatment through catheter ablation and contribute to decrease the huge burden of AF in Europe. The BEAT-AF project kicked off in 2021 and will run until 2026. The department of electrophysiology of the AZ Sint-Jan Hospital in Bruges is partner in the project and has so far contributed to the pre-clinical development, the first in man studies and first registries of the revolutionary AF treatment put forward by the consortium. The first pilot studies show that the treatment is safe, effective and efficient.